Search research articles
Contact Us
Filters
Showing results (431-440 of 465) with videos related to
Page
of 47
Sort By:
Cell Transplantation
|
April 4, 2026
Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation
Ya Luo, Ying Wu, Qiu-Sha Huang, et al.
British Journal of Haematology
|
September 3, 2025
The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation
Xu-Ying Pei, Xian-Ying Yin, Hai-Lu Sun, et al.
Annals of Translational Medicine
|
May 13, 2020
A quality evaluation of guidelines on five different viruses causing public health emergencies of international concern
Siya Zhao, Jin Cao, Qianling Shi, et al.
Bone Marrow Transplantation
|
August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective study
Si-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Journal of Hematology & Oncology
|
March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR<sup>-</sup>/<sup>low</sup>CD33<sup>+</sup>CD16<sup>-</sup>) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
Ke Wang, Meng Lv, Ying-Jun Chang, et al.
British Journal of Haematology
|
September 28, 2024
Mega-dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II study
Meng Lv, Chen-Hua Yan, Rui Ma, et al.
Bone Marrow Transplantation
|
January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors
Meng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Blood
|
May 25, 2022
An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study
Si-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Cancer
|
January 6, 2025
Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemia
Lulu Wang, Yuxiu Chen, Mengtong Zang, et al.
Bone Marrow Transplantation
|
December 1, 2022
Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection
Xueyan Sun, Haixia Fu, Chencong Wang, et al.
Page
of 47
Search research articles
Search
Showing results (431-440 of 465) with videos related to
Sort By:
Page
of 47
Cell Transplantation
|
April 4, 2026
Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation
Ya Luo, Ying Wu, Qiu-Sha Huang, et al.
British Journal of Haematology
|
September 3, 2025
The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation
Xu-Ying Pei, Xian-Ying Yin, Hai-Lu Sun, et al.
Annals of Translational Medicine
|
May 13, 2020
A quality evaluation of guidelines on five different viruses causing public health emergencies of international concern
Siya Zhao, Jin Cao, Qianling Shi, et al.
Bone Marrow Transplantation
|
August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective study
Si-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Journal of Hematology & Oncology
|
March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR<sup>-</sup>/<sup>low</sup>CD33<sup>+</sup>CD16<sup>-</sup>) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
Ke Wang, Meng Lv, Ying-Jun Chang, et al.
British Journal of Haematology
|
September 28, 2024
Mega-dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II study
Meng Lv, Chen-Hua Yan, Rui Ma, et al.
Bone Marrow Transplantation
|
January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors
Meng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Blood
|
May 25, 2022
An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study
Si-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Cancer
|
January 6, 2025
Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemia
Lulu Wang, Yuxiu Chen, Mengtong Zang, et al.
Bone Marrow Transplantation
|
December 1, 2022
Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection
Xueyan Sun, Haixia Fu, Chencong Wang, et al.
Page
of 47